The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Name: The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks
Published: 2018
License: Public Domain

Vabiotech · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

diphtheria hepatitis-b na pertussis

diphtheria, tetanus, pertussis, hepatitis b, haemophilus influenzae type b, interventional, na

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Related documents